2023
DOI: 10.1016/j.cimid.2023.102035
|View full text |Cite
|
Sign up to set email alerts
|

Serological evidence of Rift Valley fever viral infection among camels imported into Southern Algeria

Melissa Katia Trabelsi,
Aissam Hachid,
Fawzi Derrar
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…A systematic review of some of the serological studies performed in Africa reported a median seroprevalence of 12.9% in sheep, 12.6% in cattle, 11.3% in wildlife and 5.9% in humans, with the range varying dramatically, especially when comparing studies during outbreaks to seroprevalence investigations [13]. Additionally, there have been multiple RVFV seropositive cases within Turkey and Tunisia to indicate presence of the virus in these areas, as well as other serological fi ndings within Algeria, Western Sahara, Libya, Iraq and Iran which might warrant further surveillance for RVFV in these regions [14][15][16][17][18][19][20][21]. A number of other studies have been conducted in Sub-Saharan Africa to investigate potential risk factors and the seroprevalence of the virus in these regions [22][23][24][25].…”
Section: Introductionmentioning
confidence: 99%
“…A systematic review of some of the serological studies performed in Africa reported a median seroprevalence of 12.9% in sheep, 12.6% in cattle, 11.3% in wildlife and 5.9% in humans, with the range varying dramatically, especially when comparing studies during outbreaks to seroprevalence investigations [13]. Additionally, there have been multiple RVFV seropositive cases within Turkey and Tunisia to indicate presence of the virus in these areas, as well as other serological fi ndings within Algeria, Western Sahara, Libya, Iraq and Iran which might warrant further surveillance for RVFV in these regions [14][15][16][17][18][19][20][21]. A number of other studies have been conducted in Sub-Saharan Africa to investigate potential risk factors and the seroprevalence of the virus in these regions [22][23][24][25].…”
Section: Introductionmentioning
confidence: 99%